Singapore, Aug. 25 -- Sharing his perspectives with BioSpectrum Asia, Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing Commercial at Avantor, reflects on how the company is shaping Asia-Pacific's fast-evolving healthcare landscape. From strengthening its product innovation pipeline and enhancing supply chain agility to embedding sustainability across operations, Avantor is driving solutions tailored to the region's unique needs. With advanced therapies, biosimilars, and personalised medicine on the rise, Rapolu highlights how Avantor is enabling biopharma partners to deliver life-changing treatments faster, more reliably, and more sustainably.

Could you share an overview of Avantor's current product innovation pipeline ta...